Research to know,
know to prevent and cure

Background:

Tumor burden and metastatic disease sites are well-established prognostic factors in many malignancies, including metastatic Renal Cell Carcinoma (mRCC)

Objective:

We aimed to evaluate the impact of bone metastasis (BM) location on clinical outcome of mRCC patients.

Figure 1: Overall Survival for the entire patient cohort.

Figure 2: Overall Survival: a Comparison Between Groups with Spinal Bone Metastasis and Non-spinal Bone Metastasis.

Last video

Posición de los trocares para cirugía laparoscópica y robótica de riñón y pélvica de acuerdo a la anatomía

View all videos

Week Article

  • Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis

    Background: Although grading systems have been proposed for chromophobe renal cell carcinoma (ChRCC), including a three-tiered system by Paner et al (Paner GP, Amin MB, Alvarado-Cabrero I, et al. A novel tumor gradingscheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol 2010;34:1233–40), none have gained clinical acceptance, and the World Health Organization (WHO) currently recommends against grading ChRCC. ...

View all articles

About us

The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.

Read more

Last Tweets

Load More...

Sponsor

Associates

You don't have permission to register